Timothy L Smith Selected Research

Timothy L Smith Research Topics

Disease

50	Rhinosinusitis 01/2022 - 02/2007
13	Asthma (Bronchial Asthma) 01/2021 - 12/2005
12	Polyps 01/2021 - 12/2005
11	Hypersensitivity (Allergy) 01/2022 - 12/2005
10	Nasal Polyps (Nasal Polyp) 01/2020 - 12/2007
6	Pain (Aches) 11/2022 - 09/2007
5	Inflammation (Inflammations) 12/2018 - 01/2011
3	Allergic Rhinitis 01/2018 - 09/2007
3	Nasal Obstruction 01/2016 - 09/2009
2	Olfaction Disorders (Cacosmia) 01/2022 - 01/2021
2	Anosmia 01/2021 - 01/2021
2	Epistaxis (Nosebleed) 05/2015 - 01/2012
2	Osteitis 05/2013 - 05/2013
2	Sinusitis 09/2012 - 01/2011
2	Hypertrophy 02/2010 - 09/2009
2	Tonsillitis 01/2008 - 01/2008
2	Infections 01/2008 - 11/2005
2	Neoplasms (Cancer) 02/2004 - 02/2003
1	Postoperative Pain 11/2022
1	Headache Disorders (Headache Syndromes) 01/2022
1	Opioid-Related Disorders (Opiate Addiction) 01/2022
1	Headache (Headaches) 01/2022
1	Congenital Abnormalities (Deformity) 10/2019
1	Cerebrospinal Fluid Rhinorrhea 02/2019
1	Spontaneous Remission 02/2019
1	Fibromyalgia (Fibrositis) 01/2017
1	Lymphoma (Lymphomas) 09/2016
1	Obstructive Sleep Apnea 01/2016
1	Paranasal Sinus Diseases 09/2015
1	Gastroesophageal Reflux (GERD) 08/2014
1	Fatigue 11/2013
1	Seasonal Allergic Rhinitis (Hay Fever) 07/2013
1	Perennial Allergic Rhinitis 07/2013
1	Disease Progression 07/2013
1	Allergic Fungal Sinusitis 02/2013
1	Hemorrhage 01/2012
1	Exanthema (Rash) 12/2008
1	Neuralgia (Stump Neuralgia) 12/2008
1	Fistula 10/2008
1	Frontal Sinusitis 10/2008
1	Diabetes Mellitus 09/2008

Drug/Important Bio-Agent (IBA)

12	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2021 - 12/2005
11	SteroidsIBA 01/2021 - 01/2011
11	Anti-Bacterial Agents (Antibiotics)IBA 01/2019 - 09/2007
8	Adrenal Cortex Hormones (Corticosteroids)IBA 01/2021 - 07/2012
5	Iron-Dextran Complex (InFed)FDA Link 01/2022 - 02/2016
3	Proteins (Proteins, Gene)FDA Link 01/2022 - 01/2020
2	Opioid Analgesics (Opioids)IBA 11/2022 - 01/2022
2	Pharmaceutical PreparationsIBA 01/2016 - 12/2008
2	CytokinesIBA 04/2014 - 11/2013
2	garenoxacinIBA 04/2007 - 11/2005
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2022
1	Biomarkers (Surrogate Marker)IBA 01/2021
1	Carrier Proteins (Binding Protein)IBA 01/2021
1	ProteomeIBA 01/2021
1	EnzymesIBA 01/2021
1	Biological ProductsIBA 01/2020
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2020
1	Interleukin-5 (Interleukin 5)IBA 01/2020
1	Interleukin-6 (Interleukin 6)IBA 01/2020
1	Interleukin-10 (Interleukin 10)IBA 01/2020
1	Interleukin-9 (Interleukin 9)IBA 01/2020
1	Interleukin-13IBA 01/2020
1	LigandsIBA 01/2020
1	Phenylthiourea (Phenylthiocarbamide)IBA 01/2018
1	Nasal Decongestants (Decongestants)IBA 09/2016
1	N 30IBA 09/2015
1	Pain-FreeIBA 08/2015
1	Cholecalciferol (Vitamin D3)FDA Link 03/2015
1	Fibroblast Growth Factor 2 (Basic Fibroblast Growth Factor)IBA 03/2015
1	montelukast (Singulair)FDA Link 08/2014
1	Mometasone Furoate (Nasonex)FDA LinkGeneric 01/2014
1	Immunoglobulin E (IgE)IBA 07/2013
1	Matrix Metalloproteinases (MMPs)IBA 05/2013
1	Matrix Metalloproteinase 9 (Gelatinase B)IBA 05/2013
1	SmokeIBA 09/2012
1	Environmental Pollutants (Pollutants, Environmental)IBA 09/2012
1	Tobacco Smoke Pollution (Passive Smoking)IBA 09/2012
1	Hemostatics (Antihemorrhagics)IBA 01/2012
1	MacrolidesIBA 11/2009
1	10-N-nonylacridinium orange (NAO)IBA 09/2009
1	Methylprednisolone FDA LinkGeneric 12/2008
1	Diphenhydramine (Benadryl)FDA LinkGeneric 12/2008
1	Gabapentin (Neurontin)FDA LinkGeneric 12/2008
1	Pregabalin (Lyrica)FDA Link 12/2008

Therapy/Procedure

35	Therapeutics 01/2021 - 02/2003
3	Reoperation 10/2019 - 03/2007
2	Perioperative Period 01/2022 - 02/2013
2	Ligation 05/2015 - 01/2012
2	Cautery 05/2015 - 01/2012
2	Postoperative Care 10/2012 - 11/2011
2	Tonsillectomy 01/2008 - 01/2008
1	Trephining 10/2019
1	Conservative Treatment 02/2019
1	Aftercare (After-Treatment) 04/2016
1	Catheters 09/2015
1	Immunotherapy 07/2013
1	Stents 01/2011
1	Drug-Eluting Stents 01/2011
1	Off-Label Use 12/2008